Literature DB >> 14455155

Massive estrogen administration in premenopausal women with metastatic breast cancer.

B J KENNEDY.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/therapy; ESTROGENS/therapy

Mesh：

Substances：

Year:  1962        PMID： 14455155     DOI： 10.1002/1097-0142(196205/06)15:3<641::aid-cncr2820150330>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

Review 1.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

2.  Letter: Breast cancer regression under oestrogen therapy.

Authors:  M L'Hermite; C Robyn; J C Heuson; M Rozencweig
Journal:  Br Med J       Date:  1974-03-02

Review 3.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

4.  Successful estrogen therapy for post-adrenalectomy relapses of breast cancer.

Authors:  J E Devitt; G E Catton
Journal:  Can Med Assoc J       Date:  1966-04-30       Impact factor: 8.262

5.  Hypothesis: breast cancer regression under oestrogen therapy.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1973-08-25

6.  Chemoendocrine therapy in advanced breast cancer.

Authors:  D T Kiang; B J Kennedy
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

7.  Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancer.

Authors:  Mary Ellen Molloy; Bethany E Perez White; Teshome Gherezghiher; Bradley T Michalsen; Rui Xiong; Hitisha Patel; Huiping Zhao; Philipp Y Maximov; V Craig Jordan; Gregory R J Thatcher; Debra A Tonetti
Journal:  Mol Cancer Ther       Date:  2014-09-09       Impact factor: 6.261

8.  Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.

Authors:  Tatsuro Yamamoto; Chiyomi Sakamoto; Hiroaki Tachiwana; Mitsuru Kumabe; Toshiro Matsui; Tadatoshi Yamashita; Masatoshi Shinagawa; Koji Ochiai; Noriko Saitoh; Mitsuyoshi Nakao
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379

9.  Toxicity of polycyclic aromatic hydrocarbons involves NOX2 activation.

Authors:  Joycelyn Smith; Rajendra Neupane; William McAmis; Udai Singh; Saurabh Chatterjee; Samir Raychoudhury
Journal:  Toxicol Rep       Date:  2019-11-06

10.  N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth.

Authors:  Wenqing Cao; ZhiFan Ma; Mark M Rasenick; ShuYan Yeh; JiangZhou Yu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.